Date: Thu, 18 Dec 1997 18:09:41 GMT
Server: Stronghold/1.3.4 Ben-SSL/1.3 Apache/1.1.3
Content-type: text/html
Content-length: 10673
Last-modified: Mon, 06 Oct 1997 14:21:28 GMT

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>
<HEAD>
<TITLE>Basics</TITLE>
<META NAME="Author" CONTENT="Nancy Everett">
<META NAME="Generator" CONTENT="NetObjects Fusion 2.0.1 for Windows">

</HEAD>

<BODY BGCOLOR="#0000FF" LINK="#FFFFFF" VLINK="#FF80C0" TEXT="#FFFFFF">

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=656>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=50 HEIGHT =22><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =50 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=5><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =5 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=476><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =476 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=125><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =125 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =115></TD>
	<TD WIDTH=481 COLSPAN=2 ALIGN="left" VALIGN="top"><IMG HEIGHT=80 WIDTH=440 SRC="../assets/images/banner1_copy.JPG"  BORDER=0  ALT="Picture" ></TD>
	<TD></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=2 HEIGHT =948></TD>
	<TD WIDTH=476><P><B><FONT SIZE="+2" FACE="Modern">the basics of the immune system</B></FONT></P><P><FONT SIZE="-1" FACE="Modern">A healthy immune system is the most successful defense against disease.&nbsp; However, at times the diseases are so devious that the immune system needs help.&nbsp; This is where CEL-SCI Corporation’s products enter the picture.</FONT></P><P><FONT SIZE="-1" FACE="Modern">The immune system is an immensely complicated system of checks and balances.&nbsp; Here are some points that would help the reader understand the basic mechanisms.</FONT></P><P><FONT SIZE="-1" FACE="Modern">The immune system is regulated by immune modulators such as cytokines (see CEL-SCI’s product Multikine).&nbsp; The function of cytokines is mainly to act as messengers, but some cytokines are also known for their direct effect (e.g. antitumor effect).&nbsp; Cytokines activate different types of cells in your body.&nbsp; These cells then produce the immune responses needed to fight off the disease.</FONT></P><P><FONT SIZE="-1" FACE="Modern">There are basically two types of immune responses.&nbsp; The first one is called a “humoral immune response” and it produces antibodies.&nbsp; Their function is to kill “free floating” disease causing agents (e.g. AIDS virus).&nbsp; The second one is called “cellular immune response” and it produces killer T-cells.&nbsp; Their function is to kill infected cells (e.g. cells infected with the HIV virus), which antibodies cannot do.</FONT></P><P><FONT SIZE="-1" FACE="Modern">During the past few years, it has been suggested that the body gives preference to one of these immune responses over the other when it fights a disease.&nbsp; Presumably, that is the case because disease causing agents generally are not responsive to one type of immune response but may be eliminated by the other type.&nbsp; For example, the HIV virus hides in human cells and causes those cells to produce more HIV virus, finally overcoming the immune system.&nbsp; More and more researchers now believe that you must induce a killer T-cell response against HIV to destroy those infected cells (see CEL-SCI’s HGP-30 AIDS vaccine).</FONT></P><P><FONT SIZE="-1" FACE="Modern">However, viruses or other disease causing agents are often capable of tricking the body into making the wrong type of immune response so that the disease is not cleared.&nbsp; Therefore, CEL-SCI has acquired the L.E.A.P.S. heteroconjugate technology.&nbsp; This technology appears to have the ability to reprogram the immune system to better control or cure the disease.</FONT></P><P><B><FONT SIZE="-1" FACE="Modern">CEL-SCI’s Three Basic Technologies</B></FONT></P><P><FONT SIZE="-1" FACE="Modern">CEL-SCI has made substantial investments in three technologies that help the immune system fight disease more effectively.</FONT></P>
<UL><P><A HREF="../html/multikine.htm"><B><FONT SIZE="-1" FACE="Modern">Multikine </B></FONT></A><B><FONT SIZE="-1" FACE="Modern"></FONT></B><FONT SIZE="-1" FACE="Modern"> is<B> </B>a mixture of human cytokines that resembles a healthy person’s immune response.&nbsp; </FONT></P><P><FONT SIZE="-1" FACE="Modern">This drug is currently in human testing with head and neck cancer, prostate cancer and AIDS. </FONT></P><P><B><FONT SIZE="-1" FACE="Modern"><U>HGP-30</B></FONT></U><A HREF="../html/_shareholder_letter.htm"><B><FONT SIZE="-1" FACE="Modern"><U> AIDS Vaccine</U></FONT></B><FONT SIZE="-1" FACE="Modern">&nbsp; </FONT></A><FONT SIZE="-1" FACE="Modern"> is a potential vaccine/treatment against HIV.&nbsp; HGP-30 has been tested in over 60 patients.&nbsp; It also is the only AIDS vaccine to ever have shown protection against challenge by a different strain of HIV then the strain from which HGP-30 is derived.</FONT></P><P><A HREF="../html/leaps.htm"><B><FONT SIZE="-1" FACE="Modern">L.E.A.P.S. Heteroconjugate</FONT></B><FONT SIZE="-1" FACE="Modern"> </FONT></A><FONT SIZE="-1" FACE="Modern"> is a technology that is intended to selectively stimulate the immune system to more effectively fight bacterial, viral, parasitic infections, cancer, and autoimmune diseases, when it cannot do so on its own. Administered like vaccines, L.E.A.P.S. heteroconjugates may provide an exciting new class of products to treat and/or prevent these diseases.&nbsp; Early targets are AIDS, herpes simplex, malaria, and tuberculosis, diseases in dire need of effective treatments and vaccines. </FONT></P>
</UL><P>&nbsp;</TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=656>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=31 HEIGHT =43><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =31 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=589><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =589 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=36><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =36 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=589><P><A HREF="../welcome.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Home</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp; </FONT><A HREF="../html/publications.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Publications</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp; </FONT><A HREF="../html/mission.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Mission</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp; </FONT><A HREF="../html/_shareholder_letter.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Shareholder Letter</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp; </FONT><A HREF="../html/product_chart.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Product Chart</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp;&nbsp; </FONT><A HREF="../html/basics.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Basics</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp;&nbsp; </FONT><A HREF="../html/questions.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Questions</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp;&nbsp; </FONT><A HREF="../html/corporate.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Corporate</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp;&nbsp; </FONT><A HREF="../html/investor.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">FY96</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica">&nbsp;&nbsp;&nbsp;&nbsp; </FONT><A HREF="../html/employment.htm"><FONT SIZE="-2" FACE="Arial,Helvetica">Employment</FONT></A><FONT SIZE="-2" FACE="Arial,Helvetica"></FONT></TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=656>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=208 HEIGHT =51><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =208 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=200><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =200 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=248><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =248 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD></TD>
	<TD WIDTH=200><P ALIGN="CENTER"><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Modern">66 Canal Center Plaza Suite 510<BR>&nbsp;Alexandria VA 22314<BR>&nbsp;USA<BR>&nbsp;Telephone: 703-549-5293<BR>&nbsp;Facsimile:&nbsp; 703-549-6269</FONT></TD>

	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=656>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=128 HEIGHT =48><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =128 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=55><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =55 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=96><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =96 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=68><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =68 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=309><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =309 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=2 HEIGHT =57></TD>
	<TD WIDTH=96 ROWSPAN=2>
	  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=3 >
	 <TR VALIGN="top" ALIGN="left">
		<TD WIDTH=90 HEIGHT=90><A HREF="../welcome.htm"><IMG HEIGHT=90 WIDTH=90 SRC="file:///"  BORDER=0  ALT=" Home " ></A></TD>
	 </TR>
	  </TABLE></TD>
	<TD COLSPAN=2></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =39></TD>
	<TD WIDTH=219 COLSPAN=3 ROWSPAN=2><P ALIGN="CENTER"><FONT COLOR="#FFFFFF" SIZE="-1" FACE="Modern">66 Canal Center Plaza Suite 510<BR>&nbsp;Alexandria VA 22314<BR>&nbsp;USA<BR>&nbsp;Telephone: 703-549-5293<BR>&nbsp;Facsimile:&nbsp; 703-549-6269</FONT></TD>

	<TD></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =48></TD>
	<TD></TD>
   </TR>
  </TABLE>

  <TABLE BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH=656>
   <TR VALIGN="top" ALIGN="left">
	<TD WIDTH=113 HEIGHT =20><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =113 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=284><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =284 HEIGHT =1 BORDER=0></TD>
	<TD WIDTH=259><IMG SRC="../assets/auto_generated_images/img_39325fe5.gif" WIDTH =259 HEIGHT =1 BORDER=0></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD HEIGHT =30></TD>
	<TD WIDTH=284><P><A HREF="http://everettcd.com"><FONT SIZE="-1" FACE="Modern">site designed and hosted by everettcd.com</FONT></A><FONT SIZE="-1" FACE="Modern"></FONT></TD>

	<TD></TD>
   </TR>
   <TR VALIGN="top" ALIGN="left">
	<TD COLSPAN=3 HEIGHT =468></TD>
   </TR>
  </TABLE>
</BODY>
</HTML>
